Literature DB >> 23695682

Crystal structures of interleukin 17A and its complex with IL-17 receptor A.

Shenping Liu1, Xi Song, Boris A Chrunyk, Suman Shanker, Lise R Hoth, Eric S Marr, Matthew C Griffor.   

Abstract

The constituent polypeptides of the interleukin-17 family form six different homodimeric cytokines (IL-17A-F) and the heterodimeric IL-17A/F. Their interactions with IL-17 receptors A-E (IL-17RA-E) mediate host defenses while also contributing to inflammatory and autoimmune responses. IL-17A and IL-17F both preferentially engage a receptor complex containing one molecule of IL-17RA and one molecule of IL-17RC. More generally, IL-17RA appears to be a shared receptor that pairs with other members of its family to allow signaling of different IL-17 cytokines. Here we report crystal structures of homodimeric IL-17A and its complex with IL-17RA. Binding to IL-17RA at one side of the IL-17A molecule induces a conformational change in the second, symmetry-related receptor site of IL-17A. This change favors, and is sufficient to account for, the selection of a different receptor polypeptide to complete the cytokine-receptor complex. The structural results are supported by biophysical studies with IL-17A variants produced by site-directed mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23695682     DOI: 10.1038/ncomms2880

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  46 in total

1.  Cutting edge: interleukin 17 signals through a heteromeric receptor complex.

Authors:  Dean Toy; David Kugler; Martin Wolfson; Tim Vanden Bos; Jesse Gurgel; Jonathan Derry; Joel Tocker; Jacques Peschon
Journal:  J Immunol       Date:  2006-07-01       Impact factor: 5.422

2.  Cutting edge: identification of a pre-ligand assembly domain (PLAD) and ligand binding site in the IL-17 receptor.

Authors:  Jill M Kramer; Walter Hanel; Fang Shen; Nilgun Isik; James P Malone; Amarnath Maitra; Wade Sigurdson; David Swart; Joel Tocker; Tian Jin; Sarah L Gaffen
Journal:  J Immunol       Date:  2007-11-15       Impact factor: 5.422

3.  Structure of IL-17A in complex with a potent, fully human neutralizing antibody.

Authors:  Stefan Gerhardt; W Mark Abbott; David Hargreaves; Richard A Pauptit; Rick A Davies; Maurice R C Needham; Caroline Langham; Wendy Barker; Azad Aziz; Melanie J Snow; Sarah Dawson; Fraser Welsh; Trevor Wilkinson; Tris Vaugan; Gerald Beste; Sarah Bishop; Bojana Popovic; Gareth Rees; Matthew Sleeman; Steven J Tuske; Stephen J Coales; Yoshitomo Hamuro; Caroline Russell
Journal:  J Mol Biol       Date:  2009-10-14       Impact factor: 5.469

4.  Interleukin-17C promotes Th17 cell responses and autoimmune disease via interleukin-17 receptor E.

Authors:  Seon Hee Chang; Joseph M Reynolds; Bhanu P Pappu; Guangjie Chen; Gustavo J Martinez; Chen Dong
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

5.  IL-17E, a novel proinflammatory ligand for the IL-17 receptor homolog IL-17Rh1.

Authors:  J Lee; W H Ho; M Maruoka; R T Corpuz; D T Baldwin; J S Foster; A D Goddard; D G Yansura; R L Vandlen; W I Wood; A L Gurney
Journal:  J Biol Chem       Date:  2001-01-12       Impact factor: 5.157

6.  IL-17RC is required for IL-17A- and IL-17F-dependent signaling and the pathogenesis of experimental autoimmune encephalomyelitis.

Authors:  Yan Hu; Naruhisa Ota; Ivan Peng; Canio J Refino; Dimitry M Danilenko; Patrick Caplazi; Wenjun Ouyang
Journal:  J Immunol       Date:  2010-03-15       Impact factor: 5.422

7.  IL-17s adopt a cystine knot fold: structure and activity of a novel cytokine, IL-17F, and implications for receptor binding.

Authors:  S G Hymowitz; E H Filvaroff; J P Yin; J Lee; L Cai; P Risser; M Maruoka; W Mao; J Foster; R F Kelley; G Pan; A L Gurney; A M de Vos; M A Starovasnik
Journal:  EMBO J       Date:  2001-10-01       Impact factor: 11.598

8.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

9.  Identification of functional roles for both IL-17RB and IL-17RA in mediating IL-25-induced activities.

Authors:  Erika A Rickel; Lori A Siegel; Bo-Rin Park Yoon; James B Rottman; David G Kugler; David A Swart; Penny M Anders; Joel E Tocker; Michael R Comeau; Alison L Budelsky
Journal:  J Immunol       Date:  2008-09-15       Impact factor: 5.422

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  32 in total

Review 1.  Focusing on shared subpockets - new developments in fragment-based drug discovery.

Authors:  Eman M M Abdelraheem; Carlos J Camacho; Alexander Dömling
Journal:  Expert Opin Drug Discov       Date:  2015-08-21       Impact factor: 6.098

Review 2.  IL-17 family: cytokines, receptors and signaling.

Authors:  Chunfang Gu; Ling Wu; Xiaoxia Li
Journal:  Cytokine       Date:  2013-09-03       Impact factor: 3.861

Review 3.  Current approaches to fine mapping of antigen-antibody interactions.

Authors:  W Mark Abbott; Melissa M Damschroder; David C Lowe
Journal:  Immunology       Date:  2014-08       Impact factor: 7.397

Review 4.  Interleukin 17 Family Cytokines: Signaling Mechanisms, Biological Activities, and Therapeutic Implications.

Authors:  Leticia Monin; Sarah L Gaffen
Journal:  Cold Spring Harb Perspect Biol       Date:  2018-04-02       Impact factor: 10.005

5.  RECK suppresses interleukin-17/TRAF3IP2-mediated MMP-13 activation and human aortic smooth muscle cell migration and proliferation.

Authors:  Srinivas Mummidi; Nitin A Das; Andrea J Carpenter; Tadashi Yoshida; Manjunath Yariswamy; Ricardo Mostany; Reza Izadpanah; Yusuke Higashi; Sergiy Sukhanov; Makoto Noda; Ulrich Siebenlist; Randy S Rector; Bysani Chandrasekar
Journal:  J Cell Physiol       Date:  2019-05-09       Impact factor: 6.384

6.  The flavonoid cyanidin blocks binding of the cytokine interleukin-17A to the IL-17RA subunit to alleviate inflammation in vivo.

Authors:  Caini Liu; Liang Zhu; Koichi Fukuda; Suidong Ouyang; Xing Chen; Chenhui Wang; Cun-Jin Zhang; Bradley Martin; Chunfang Gu; Luke Qin; Suguna Rachakonda; Mark Aronica; Jun Qin; Xiaoxia Li
Journal:  Sci Signal       Date:  2017-02-21       Impact factor: 8.192

7.  Artificial Macrocycles as IL-17A/IL-17RA Antagonists.

Authors:  Wenjia Wang; Matthew R Groves; Alexander Dömling
Journal:  Medchemcomm       Date:  2017-10-25       Impact factor: 3.597

8.  Characterization of Lamprey IL-17 Family Members and Their Receptors.

Authors:  Qifeng Han; Sabyasachi Das; Masayuki Hirano; Stephen J Holland; Nathanael McCurley; Peng Guo; Charles S Rosenberg; Thomas Boehm; Max D Cooper
Journal:  J Immunol       Date:  2015-10-21       Impact factor: 5.422

9.  Divergent functions of IL-17-family cytokines in DSS colitis: Insights from a naturally-occurring human mutation in IL-17F.

Authors:  Chunsheng Zhou; Dongwen Wu; Chetan Jawale; Yang Li; Partha S Biswas; Mandy J McGeachy; Sarah L Gaffen
Journal:  Cytokine       Date:  2021-09-26       Impact factor: 3.861

10.  Expression and Function Analysis of Interleukin-17A/F1, 2, and 3 Genes in Yellow Catfish (Pelteobagrus fulvidraco): Distinct Bioactivity of Recombinant IL-17A/F1, 2, and 3.

Authors:  Xu Zhou; Gui-Rong Zhang; Wei Ji; Ze-Chao Shi; Xu-Fa Ma; Zun-Lan Luo; Kai-Jian Wei
Journal:  Front Immunol       Date:  2021-06-29       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.